This site is targeted at medical and radiology professionals, contains user contributed content, and material that may be confusing to a lay audience. Use of this site implies acceptance of our Terms of Use.

Cornelia de Lange syndrome

The Cornelia de Lange syndrome (CdLS) is an extremely rare clinically heterogenous developmental disorder of unknown aetiology.

Epidemiology

The estimated incidence is at ~ 1 : 10,000 - 160,000 births ref. There is no recognised racial or gender predilection 8.

Clinical spectrum

The syndrome carries a wide spectrum of clinical features which include

Pathology

Genetics

Most cases are thought to be sporadic resulting in a new autosomal dominant mutation 8. Occasional autosomal dominant and autosomal recessive forms are known. Some have abnormalities in chromosome 3q26.3. Heterozygous mutations in the cohesin regulator, NIPBL, or the cohesin structural components SMC1A and SMC3, have been identified in approximately 65% of individuals with CdLS 6.

Markers

  • abnormally low maternal serum alpha feto protein (MSAFP) * levels have been described in some cases 12.

Radiographic features

Antenatal ultrasound

May demonstrate many of the above clinical features. An early (first trimester) ultrasound scan may show an increased nuchal translucency as a non specific but early sign 4,13.

Etymology

It was inititially described by Brachmann in 1916 5 but described in its full clinical presentation by Cornelia de Lange in 1933.

This article is a stub, which means it needs more content. You can contribute to Radiopaedia.org too. Just register and edit... every little bit helps.

Updating… Please wait.
Loadinganimation

 Details successfully updated.

Error Unable to process the form. Check for errors and try again.

 Thank you for updating your details.